Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
Novartis
Novartis
National Institutes of Health Clinical Center (CC)
Takeda
University of Illinois at Chicago
Centre Oscar Lambret
Institut Paoli-Calmettes
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Chicago
Incyte Corporation
University of Nebraska
Henan University
Massachusetts General Hospital
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Massachusetts General Hospital
Roswell Park Cancer Institute
Group for Research in Adult Acute Lymphoblastic Leukemia
Gamida Cell ltd
Columbia University
National Institutes of Health Clinical Center (CC)
BeOne Medicines
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Merck Sharp & Dohme LLC
University of Kentucky
M.D. Anderson Cancer Center